Elevance Health Inc. (NYSE: ELV) reported Q1 EPS of $10.64, $0.16 better than the analyst estimate of $10.48. Revenue for the quarter came in at $42.3 billion versus the consensus estimate of $42.47 billion.

GUIDANCE:

Elevance Health Inc. sees FY2024 EPS at greater of $37.20, versus the consensus of $37.15.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.